by Tom Salemi
Their searches have led them primarily to Europe, where a shared history and far more predictable regulatory path beckon. Start-ups...
Device Companies Look West, East, Anyplace But US
With clear regulatory approval paths in Europe and growing markets in Asia and other developing markets, device executives and investors see international markets as increasingly attractive alternatives for clinical validation, revenue, and regulatory approval.